COASTLANDS CAPITAL LP enters ADIAL PHARMACEUTICALS, INC. with 348.32K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 6/29/2026ACC: 0001104659-26-078710
10% Owner
Since Jun 2026
348.32K
Baseline shares
0.00
Direct ownership
0 positions
3.64M
Derivative underlying
1 instrument
1
Security positions
348.32K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned348.32K
Total
348.32K indirect348.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 348.32K | Indirect |
| Total | 348.32K | 348.32K indirect |
Derivative Holdings1
Pre-funded Warrant
IndirectUnderlying security
Common Stock
Underlying shares
3.64M
Shares owned
N/A
Exercise price
0.001
Expiration
—
Exercise window
—
Total
Underlying
3.64M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-funded Warrant Indirect | Common Stock | 0.001 | — | — | 3.64M | N/A |
| Total | 3.64M | 0.00 | ||||